Don’t miss this opportunity to connect with THE cannabis movers and shakers from across the globe during Benzinga’s Virtual Cannabis Capital Conference on October 15. Among the attendees is Avicanna.
Located in the Discovery District of Toronto, Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company.
The company’s focus over the past 5 years has been research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
With an emphasis on research and development, Avicanna is comprised of a team of clinicians, biotech executives and over 10 scientists. Avicanna’s research and medical team determine ratios, doses and delivery forms to provide advanced non-inhalation treatments that are now commercial in Canada. Their research aims to aid various medical conditions such as nausea, osteoarthritis, chronic pain and more.
CEO &…
